Bayer and Tianwu Tech Forge Strategic Partnership: AI-Powered Protein Design Drives Innovation in Consumer Health

November 7,Bayer HealthCare LLCWith member unitsMatwings TechnologyInThe 8th China International Import Expo (CIIE)Signed a strategic cooperation agreement, announcing that the two parties will further deepen the cooperation in AI technology within Bayer's consumer health sector, focusing on scientific research exploration, new product development, and application transformation. They will continue to explore the application of intelligent protein molecular design and biomanufacturing innovation in gastrointestinal and skin health fields, jointly promoting the development of artificial intelligence in personalized health management and self-care.

As a life sciences company with over 160 years of history, Bayer has core competencies in the healthcare and agriculture sectors. This signing represents an enhancement and upgrade of the previous cooperation between the two parties, aiming to improve R&D efficiency through large AI models and accelerate the process of bringing new products with market potential from concept to commercialization.

Representatives of the signing: Li Xiaomeng, Head of R&D for Bayer HealthCare Consumer Products in China, and Lu Xingyu, Head of the AI + Enzyme Catalysis Platform at Matwings Technology

Witnesses: Yong He, General Manager of Bayer HealthCare Consumer Products China; Liang Hong, Chief Scientist of Matwings Technology and Director of the AI Biomedicine Center at Zhangjiang Institute of Advanced Research, Shanghai Jiao Tong University

Yong He, General Manager of Bayer HealthCare Consumer Products China"AI is a key force in reshaping the health industry. Bayer HealthCare will continue to increase its investment and exploration in AI + life sciences, focusing on intelligent R&D and consumer health management, expanding the application boundaries of AI in the health consumption field, and jointly promoting the intelligent and precise transformation of the health consumption industry."

Liang Hong, Chief Scientist of Matwings Technology and Distinguished Professor at Shanghai Jiao Tong UniversitySaid: "We will fully leverage Matwings Technology's technical advantages in artificial intelligence, synthetic biology, and biomedicine, combined with Bayer's deep insights and industrialization capabilities in the life sciences field, to jointly explore new paths for intelligent R&D, develop more high-quality and innovative health products, and contribute wisdom to the advancement of the health industry."

About Bayer

Bayer, as a multinational enterprise, possesses core competitiveness in healthcare and agriculture within the life sciences field. Guided by the mission of "Shared Health, Eliminating Hunger," the company is committed to helping people overcome major challenges posed by global population growth and aging through its products and services, benefiting humanity and promoting the prosperity of the planet. Bayer is dedicated to advancing sustainability and positively impacting its business. Meanwhile, the group enhances profitability and creates value through technological innovation and business growth. Globally, the Bayer brand stands for trust, reliability, and quality. In the 2024 fiscal year, Bayer employed approximately 93,000 people and generated sales of 46.6 billion euros. Research and development expenditure, excluding special items, amounted to 6.2 billion euros.

About Matwings Technology

Matwings Technology, established in 2021 by an elite team from Shanghai Jiao Tong University, is a global leader in AI-driven protein design. Committed to utilizing advanced artificial intelligence technologies, the company provides comprehensive, end-to-end AI protein solutions for biomedicine, synthetic biology, and other fields, covering everything from protein design, experimental validation, pilot testing, and scale-up to commercial production. Matwings Technology’s self-developed universal large-scale AI model, AIACCLBIOTM, features two core functionalities: "AI-directed evolution" and "AI enzyme mining." Leveraging this powerful model, Matwings Technology has successfully delivered over thirty protein projects, earning recognition from multiple industry-leading clients and forming close, long-term strategic partnerships with numerous upstream and downstream enterprises.